https://www.selleckchem.com/pr....oducts/gsk2141795.ht
91 ± 0.13; Post 1.02 ± 0.16; p = 0.001] despite a decrease in HDL-C levels. The change in CEC correlated with the change in apo A-I (r = 0.39, p = 0.02) and adiponectin levels (r = 0.35, p = 0.03). The results suggest that improvements in CEC, through improvement in adipose tissue health in terms of adipokine secretion and insulin sensitivity could be an important pathway in modulating obesity-related CVD risk. The results suggest that improvements in CEC, through improvement in adipose tissue health in terms of adipokine secretion a